AltaThera Pharmaceuticals showcased Sotalol IV at Heart Rhythm Society’s annual meeting in Boston from May 16-19, 2024. Serving as a hub for innovation, discovery, and connection, HRS brings the world of electrophysiology together with over 8,500 attendees from around the world.
AltaThera Pharmaceuticals will showcase its antiarrhythmic product, Sotalol IV, at the upcoming American College of Cardiology 2024 annual meeting in Atlanta, Georgia from April 6-8. With attendees coming from around the world, ACC.24 provides an ideal venue to learn about the latest science and practice-changing updates in cardiovascular care.
AltaThera Pharmaceuticals will be presenting its data at the 29th Annual AF Symposium at the Omni Boston at the Seaport from February 1-3. This intensive symposium brings together the world’s leading medical scientists to share recent advances in the field of atrial fibrillation.